Bayer CEO Werner Baumann called the decision to settle the lawsuits the right one in order to end a long period of uncertainty.
“The decision to resolve the Roundup litigation enables us to focus fully on the critical supply of health care and food,” he said in a statement. “It will also return the conversation about the safety and utility of glyphosate-based herbicides to the scientific and regulatory arena and to the full body of science.”
Let our news meet your inbox. The news and stories that matter, delivered weekday mornings.
The settlement, however, does not contain any admission of wrongdoing or liability.
Bayer will pay $8.8 billion to $9.6 billion to settle existing lawsuits and then another $1.25 billion that will cover any potential litigation in the future, the company said in a press release Wednesday.
Kenneth Feinberg, a court-appointed mediator for the settlement, called the deal a “constructive and reasonable” resolution.
“The significant progress made to date — which exceeds the initial participation rates of other claims resolution proceedings — provides a robust framework that will enable the parties to bring closure to the current Roundup litigation in due course,” he said in the statement from Bayer.
A jury awarded the California groundskeeper, Dewayne Johnson, nearly $290 million in damages in August 2018 after it found Monsanto failed to warn Johnson and other consumers about the risks posed by its weed-killing products. A judge upheld the decision upon appeal but lowered the damages to $78 million due to what she considered an overreach in punitive damages decided by the jury.
German pharmaceuticals and chemical giant Bayer bought Monsanto in 2018 just months before Johnson won his suit against the company. Bayer eliminated the Monsanto name, but maintained the brands and folded them into its portfolio.
Doha Madani is a breaking news reporter for NBC News.